Good Manufacturing Practices licence granted

Company news

27 Oct 2020

LGP Manufacturing 1200x1200

Little Green Pharma was recently granted a Therapeutic Goods Administration (TGA) Good Manufacturing Practices (GMP) licence for its recently commissioned manufacturing facility in Western Australia. This license means:

  • LGP will now be able to produce medicinal cannabis flower products
  • LGP has the benefit of enhanced manufacturing capacity in addition to our existing pharmaceutical manufacturer
  • strong supply reliability for patients

The GMP licencing of the Company’s manufacturing facility is the culmination of a two-year regulatory strategy.

Little Green Pharma now holds over 20 State and Federal operating authorisations, allowing it to operate a fully in-house and vertically-integrated cannabis cultivation, production, manufacturing, and wholesaling supply chain, capable of supplying various LGP branded medicinal cannabis products into Australian and international markets.

The manufacturing facility was constructed with funding support from the West Australian Government and represents a regional manufacturing success story for South West Western Australia.

You might also be interested in

Medical portal screengrab

Company news

LGP's NEW Medical Portal
Little Green Pharma launches its NEW Medical Portal for Healthcare Professionals. Access education, case studies, product and dosing information, events and loads more.

Aug 2020

STATS 310321 FB 940x788

Insights

Industry update: March 2021
The TGA approval numbers just keep on climbing

Apr 2021

German Exports Approved for Little Green Pharma Flag

Company news

First Export Milestone Achieved

Little Green Pharma reaches a significant milestone becoming the first Australian medicinal cannabis producer to export samples of locally grown medicinal cannabis product to Germany.

Sep 2019

View all articles